ENTRY       3593              CDS       T01001
NAME        IL12B, CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF, NKSF2
DEFINITION  (RefSeq) interleukin 12B
ORTHOLOGY   K05425  interleukin 12B
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa04060  Cytokine-cytokine receptor interaction
            hsa04620  Toll-like receptor signaling pathway
            hsa04622  RIG-I-like receptor signaling pathway
            hsa04630  Jak-STAT signaling pathway
            hsa04658  Th1 and Th2 cell differentiation
            hsa04940  Type I diabetes mellitus
            hsa05133  Pertussis
            hsa05134  Legionellosis
            hsa05140  Leishmaniasis
            hsa05142  Chagas disease (American trypanosomiasis)
            hsa05143  African trypanosomiasis
            hsa05145  Toxoplasmosis
            hsa05146  Amoebiasis
            hsa05152  Tuberculosis
            hsa05162  Measles
            hsa05164  Influenza A
            hsa05168  Herpes simplex infection
            hsa05205  Proteoglycans in cancer
            hsa05321  Inflammatory bowel disease (IBD)
            hsa05330  Allograft rejection
DISEASE     H00089  IFN-gamma/IL-12 axis
DRUG_TARGET Apilimod mesylate: D06556
            Lisofylline: D04748
            Ustekinumab: D09214
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04630 Jak-STAT signaling pathway
                3593 (IL12B)
              Signaling molecules and interaction
               04060 Cytokine-cytokine receptor interaction
                3593 (IL12B)
             Organismal Systems
              Immune system
               04620 Toll-like receptor signaling pathway
                3593 (IL12B)
               04622 RIG-I-like receptor signaling pathway
                3593 (IL12B)
               04658 Th1 and Th2 cell differentiation
                3593 (IL12B)
             Human Diseases
              Cancers
               05205 Proteoglycans in cancer
                3593 (IL12B)
              Immune diseases
               05321 Inflammatiory bowel disease (IBD)
                3593 (IL12B)
               05330 Allograft rejection
                3593 (IL12B)
              Endocrine and metabolic diseases
               04940 Type I diabetes mellitus
                3593 (IL12B)
              Infectious diseases
               05133 Pertussis
                3593 (IL12B)
               05134 Legionellosis
                3593 (IL12B)
               05152 Tuberculosis
                3593 (IL12B)
               05162 Measles
                3593 (IL12B)
               05164 Influenza A
                3593 (IL12B)
               05168 Herpes simplex infection
                3593 (IL12B)
               05146 Amoebiasis
                3593 (IL12B)
               05145 Toxoplasmosis
                3593 (IL12B)
               05140 Leishmaniasis
                3593 (IL12B)
               05142 Chagas disease (American trypanosomiasis)
                3593 (IL12B)
               05143 African trypanosomiasis
                3593 (IL12B)
            Cytokines [BR:hsa04052]
             Class I cytokines (hematopoietin family)
              IL-6 receptor family
               3593 (IL12B)
            Glycosaminoglycan binding proteins [BR:hsa00536]
             Heparan sulfate/Haparin
              Cytokines	(General comment) Chemotaxis, singal transduction, inflammation
               3593 (IL12B)
POSITION    5q33.3
MOTIF       Pfam: IL12p40_C Ig_3 Ig_5 Ig_2 fn3 Ig_4 I-set
DBLINKS     NCBI-GeneID: 3593
            NCBI-ProteinID: NP_002178
            OMIM: 161561
            HGNC: 5970
            Ensembl: ENSG00000113302
            Vega: OTTHUMG00000130307
            Pharos: P29460(Tclin)
            UniProt: P29460
STRUCTURE   PDB: 5MJ3 3D85 3DUH 1F42 4GRW 1F45 3D87 3HMX 3QWR 5MJ4
AASEQ       328
            MCHQQLVISWFSLVFLASPLVAIWELKKDVYVVELDWYPDAPGEMVVLTCDTPEEDGITW
            TLDQSSEVLGSGKTLTIQVKEFGDAGQYTCHKGGEVLSHSLLLLHKKEDGIWSTDILKDQ
            KEPKNKTFLRCEAKNYSGRFTCWWLTTISTDLTFSVKSSRGSSDPQGVTCGAATLSAERV
            RGDNKEYEYSVECQEDSACPAAEESLPIEVMVDAVHKLKYENYTSSFFIRDIIKPDPPKN
            LQLKPLKNSRQVEVSWEYPDTWSTPHSYFSLTFCVQVQGKSKREKKDRVFTDKTSATVIC
            RKNASISVRAQDRYYSSSWSEWASVPCS
NTSEQ       987
            atgtgtcaccagcagttggtcatctcttggttttccctggtttttctggcatctcccctc
            gtggccatatgggaactgaagaaagatgtttatgtcgtagaattggattggtatccggat
            gcccctggagaaatggtggtcctcacctgtgacacccctgaagaagatggtatcacctgg
            accttggaccagagcagtgaggtcttaggctctggcaaaaccctgaccatccaagtcaaa
            gagtttggagatgctggccagtacacctgtcacaaaggaggcgaggttctaagccattcg
            ctcctgctgcttcacaaaaaggaagatggaatttggtccactgatattttaaaggaccag
            aaagaacccaaaaataagacctttctaagatgcgaggccaagaattattctggacgtttc
            acctgctggtggctgacgacaatcagtactgatttgacattcagtgtcaaaagcagcaga
            ggctcttctgacccccaaggggtgacgtgcggagctgctacactctctgcagagagagtc
            agaggggacaacaaggagtatgagtactcagtggagtgccaggaggacagtgcctgccca
            gctgctgaggagagtctgcccattgaggtcatggtggatgccgttcacaagctcaagtat
            gaaaactacaccagcagcttcttcatcagggacatcatcaaacctgacccacccaagaac
            ttgcagctgaagccattaaagaattctcggcaggtggaggtcagctgggagtaccctgac
            acctggagtactccacattcctacttctccctgacattctgcgttcaggtccagggcaag
            agcaagagagaaaagaaagatagagtcttcacggacaagacctcagccacggtcatctgc
            cgcaaaaatgccagcattagcgtgcgggcccaggaccgctactatagctcatcttggagc
            gaatgggcatctgtgccctgcagttag
///
